PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while IXX.DE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y CAGR while IXX.DE stands at 103.08%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Negative 3Y CAGR while IXX.DE stands at 70.63%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y OCF/share CAGR while IXX.DE is at 81.49%. Joel Greenblatt would question the firm’s operational model or cost structure.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y net income/share CAGR while IXX.DE is 59.54%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-100.00%
Negative 3Y CAGR while IXX.DE is 42.49%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y equity/share growth while IXX.DE is at 59.14%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-100.00%
Negative 3Y equity/share growth while IXX.DE is at 31.78%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-4.57%
Firm’s AR is declining while IXX.DE shows 23.87%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
20.58%
We show growth while IXX.DE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
21.66%
Asset growth above 1.5x IXX.DE's 1.10%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-100.00%
We have a declining book value while IXX.DE shows 10.52%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
80.69%
We have some new debt while IXX.DE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.